Synthera Biomedical Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.14 M
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 369.59%
- Profit Growth 134.38%
- Ebitda -122.30%
- Net Worth 1.70%
- Total Assets 61.10%
About Synthera Biomedical
Synthera Biomedical Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 June 2015 (Nine years and seven months 15 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.14 M, as per Ministry of Corporate Affairs (MCA) records.
Nilay Lakhkar, Jayant Lakhkar, Natasha Kothari, and One other member serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33111PN2015PTC155498
-
Company No.
155498
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Jun 2015
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Synthera Biomedical?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilay Lakhkar
|
Director | 19-Jun-2015 | Current |
|
Jayant Lakhkar
|
Director | 19-Jun-2015 | Current |
|
Natasha Kothari
|
Nominee Director | 15-Jun-2018 | Current |
|
Mugdha Lele
|
Nominee Director | 23-Sep-2015 | Current |
Financial Performance of Synthera Biomedical.
Synthera Biomedical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 369.59% increase. The company also saw a substantial improvement in profitability, with a 134.38% increase in profit. The company's net worth moved up by a moderate rise of 1.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Synthera Biomedical?
In 2021, Synthera Biomedical had a public holding of 28.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Spot Healthcare Solutions Private LimitedMugdha Lele is a mutual person
-
Pragmatech Healthcare Solutions Private LimitedMugdha Lele is a mutual person
-
Zeva Capsol Private LimitedNatasha Kothari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Synthera Biomedical?
Unlock and access historical data on people associated with Synthera Biomedical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Synthera Biomedical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthera Biomedical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
